Xylem Inc. (NYSE:XYL) – Investment analysts at Northcoast Research issued their FY2016 EPS estimates for Xylem in a research note issued to investors on Thursday. Northcoast Research analyst A. Cohen anticipates that the brokerage will earn $2.04 per share for the year. Northcoast Research currently has a “Buy” rating on the stock. Northcoast Research also issued estimates for Xylem’s Q4 2016 earnings at $0.67 EPS, Q1 2017 earnings at $0.53 EPS, Q2 2017 earnings at $0.67 EPS, Q3 2017 earnings at $0.68 EPS, Q4 2017 earnings at $0.82 EPS and FY2017 earnings at $2.70 EPS.

A number of other equities analysts have also recently issued reports on the company. Atlantic Securities upgraded Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 price objective for the company in a report on Monday, August 22nd. Stifel Nicolaus upped their price objective on Xylem from $47.00 to $48.00 and gave the stock a “hold” rating in a report on Wednesday, November 2nd. Canaccord Genuity reiterated a “hold” rating and issued a $50.00 price objective (up from $45.00) on shares of Xylem in a report on Tuesday, August 16th. Janney Montgomery Scott upgraded Xylem from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $50.00 to $52.00 in a report on Wednesday, November 2nd. Finally, Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $58.00 price objective (up from $55.00) on shares of Xylem in a report on Monday. Eight equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $47.15.

Earnings History and Estimates for Xylem (NYSE:XYL)

Shares of Xylem (NYSE:XYL) opened at 52.92 on Monday. The company has a market capitalization of $9.49 billion, a P/E ratio of 29.37 and a beta of 1.18. Xylem has a one year low of $31.67 and a one year high of $54.99. The firm has a 50-day moving average price of $50.29 and a 200-day moving average price of $48.16.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, November 1st. The company reported $0.54 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.01. The business earned $897 million during the quarter, compared to the consensus estimate of $913.53 million. Xylem had a return on equity of 16.38% and a net margin of 8.83%. The firm’s revenue for the quarter was down .6% on a year-over-year basis. During the same period in the previous year, the company posted $0.49 earnings per share.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 7th. Shareholders of record on Wednesday, November 9th will be given a dividend of $0.1549 per share. This represents a $0.62 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Monday, November 7th. Xylem’s payout ratio is 34.44%.

In other news, insider Colin R. Sabol sold 27,473 shares of the stock in a transaction that occurred on Thursday, September 8th. The stock was sold at an average price of $50.91, for a total value of $1,398,650.43. Following the completion of the transaction, the insider now owns 65,530 shares of the company’s stock, valued at approximately $3,336,132.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Claudia S. Toussaint sold 5,300 shares of the stock in a transaction that occurred on Friday, November 4th. The stock was sold at an average price of $47.27, for a total value of $250,531.00. Following the completion of the transaction, the senior vice president now directly owns 44,033 shares of the company’s stock, valued at approximately $2,081,439.91. The disclosure for this sale can be found here. Company insiders own 0.77% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in XYL. Delaney Dennis R raised its position in shares of Xylem by 0.3% in the second quarter. Delaney Dennis R now owns 6,007 shares of the company’s stock valued at $269,000 after buying an additional 20 shares in the last quarter. Dempze Nancy E raised its position in shares of Xylem by 0.3% in the second quarter. Dempze Nancy E now owns 16,760 shares of the company’s stock valued at $748,000 after buying an additional 50 shares in the last quarter. Sanders Morris Harris Inc. raised its position in shares of Xylem by 1.3% in the second quarter. Sanders Morris Harris Inc. now owns 6,410 shares of the company’s stock valued at $286,000 after buying an additional 85 shares in the last quarter. Utah Retirement Systems raised its position in shares of Xylem by 0.3% in the second quarter. Utah Retirement Systems now owns 32,565 shares of the company’s stock valued at $1,454,000 after buying an additional 100 shares in the last quarter. Finally, National Asset Management Inc. raised its position in shares of Xylem by 1.4% in the third quarter. National Asset Management Inc. now owns 7,002 shares of the company’s stock valued at $368,000 after buying an additional 100 shares in the last quarter. 84.62% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Northcoast Research Weighs in on Xylem Inc.’s FY2016 Earnings (XYL)” was first posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this report on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this report can be read at https://www.thecerbatgem.com/2016/11/23/northcoast-research-weighs-in-on-xylem-inc-s-fy2016-earnings-xyl.html.

Xylem Company Profile

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.